Inventor · disambiguated record
Daniel J. Cua
Also filed as: CUA DANIEL · CUA DANIEL J
11 granted patents·19 pending applications·120 citations·filing 2003–2022
90Inventor score
Top patents by PatentIndex Score
30 records- 0193US7575741B2Methods of treating cutaneous ulcers and grafts using IL-23SCHERING CORP·Filed 2008·Granted Aug 18, 2009·27 cites·15 claims
- 0292US7820168B2Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17SCHERING CORP·Filed 2005·Granted Oct 26, 2010·16 cites·20 claims
- 0392US7332156B2Methods of treating wounds using IL-23SCHERING CORP·Filed 2003·Granted Feb 19, 2008·46 cites·15 claims
- 0491US7893215B2Agonist antibodies to IL-23 receptorSCHERING CORP·Filed 2009·Granted Feb 22, 2011·17 cites·8 claims
- 0584US8263080B2Use of agonists and antagonists of IL-23 in the treatment of viral infectionKATSIKIS PETER D·Filed 2005·Granted Sep 11, 2012·8 cites·13 claims
- 0672US12037393B2P116 antibodiesMERCK SHARP & DOHME LLC·Filed 2022·Granted Jul 16, 2024·0 cites·13 claims
- 0770US8524230B2Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory diseaseCUA DANIEL J·Filed 2009·Granted Sep 3, 2013·2 cites·1 claims
- 0870US8062634B2Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptorBOWMAN EDWARD P·Filed 2011·Granted Nov 22, 2011·2 cites·9 claims
- 0969US8691227B2Methods of treating multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease using agonists antibodies to PILR-αTATO CRISTINA M·Filed 2010·Granted Apr 8, 2014·2 cites·6 claims
- 1061US2009092604A1Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 ActivitySCHERING CORP·Filed 2008·Application pending·0 cites
- 1159US2010135998A1Combination therapy for treatment of immune disordersSCHERING CORP·Filed 2008·Application pending·0 cites
- 1258US2014248279A1Use of il-23 and il-17 antiagonists to treat autoimmune ocular inflammatory diseaseMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1357US9284377B2MDL-1 ligandMERCK SHARP & DOHME·Filed 2015·Granted Mar 15, 2016·0 cites·5 claims
- 1455US2008199460A1Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory diseaseUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1555US2010221252A1Mdl-1 usesSCHERING CORP·Filed 2008·Application pending·0 cites
- 1655US2014234301A1Modulation of PILR to Treat Immune DisordersMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1754US2006140950A1Uses of mammalian cytokine; related reagentsSCHERING CORP·Filed 2006·Application pending·0 cites
- 1854US2013323251A1Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory diseaseGOVERNMENT OF THE US SECRETARY OF THE DEP OF H H S·Filed 2013·Application pending·0 cites
- 1954US2013287775A1Combination therapy for treatment of immune disordersMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2053US2011002928A1Uses of Mammalian Cytokine; Related ReagentsSCHERING CORP·Filed 2010·Application pending·0 cites
- 2151US2011142831A1Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory diseaseSCHERING CORP·Filed 2011·Application pending·0 cites
- 2250US11370839B2ILT3 ligandCUA DANIEL·Filed 2017·Granted Jun 28, 2022·0 cites·18 claims
- 2350US2004219150A1Uses of mammalian cytokine; related reagentsFiled 2004·Application pending·0 cites
- 2449US2012052044A1Uses of mammalian cytokine; related reagentsBOWMAN EDWARD P·Filed 2011·Application pending·0 cites
- 2549US2014227719A1Mdl-1 ligandMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 2647US2010143357A1Uses of Mammalian Cytokine; Related ReagentsSCHERING CORP·Filed 2010·Application pending·0 cites
- 2745US2012156699A1Pathogenic TH17 Cells; related reagents and methodsBOWMAN EDWARD P·Filed 2012·Application pending·0 cites
- 2844US2012177647A1Mdl-1 usesBIGLER MICHAEL E·Filed 2012·Application pending·0 cites
- 2941US2014286946A1Method for preparing antibodies having improved propertiesMERCK SHARP & DOHME·Filed 2012·Application pending·0 cites
- 3033US2013323246A1Use of mdl-1 antagonists to treat spondylarthropathyCUA DANIEL J·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →